Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna: 2025 Contrarian Play
12:46pm, Tuesday, 31'st Dec 2024
Moderna ends 2024 as one of the worst-performing Nasdaq-100 stocks, but it presents a contrarian play for 2025 due to vaccine catalysts. The stock is down to $40 with a $15 billion market cap, despite
Wall Street's top 5 stocks with the biggest upside in 2025
06:15am, Thursday, 26'th Dec 2024
As 2024 is nearing its end, investors with a time machine are looking to visit December 2023 and take their long positions in Nvidia (NASDAQ: NVDA), Tesla (NASDAQ: TSLA), Super Micro Computer (NASDAQ:
mRNA Vaccines and Therapeutics Market Expected to Reach USD 253.83 Billion By 2034, With 16.7% CAGR From 2025 to 2034 | PMR
02:00am, Thursday, 26'th Dec 2024
The global market for mRNA vaccines and therapeutics is expanding due to the rising incidence of chronic illnesses worldwide. The global market for mRNA vaccines and therapeutics is expanding due to t
Moderna Stock Down 39% in Three Months: Buy the Dip or Wait?
09:05am, Monday, 23'rd Dec 2024
Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point by another two years to 2028.
Is Moderna Stock a Buy?
06:45am, Friday, 20'th Dec 2024
Moderna's (MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock price have been moving in the wrong direction for the past three years, a pe
3 Stocks That Could Turn $1,000 into $5,000 by 2030
04:50am, Friday, 20'th Dec 2024
A five-bagger in only five years? Any investor would love to buy such a stock.
This Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It Is
11:13am, Wednesday, 18'th Dec 2024
The incredible returns equity investors have seen in 2024, and over the past couple months for that matter, have been incredible.
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
05:44am, Wednesday, 18'th Dec 2024
Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the inherent risks of developing new drugs.
3-Stock Lunch: Palantir, MicroStrategy and Moderna
03:30pm, Monday, 16'th Dec 2024
Steve Grasso, Grasso Global CEO, joins 'Power Lunch' to discuss stock plays for three stocks.
MSTR & PLTR Joins the NDX, SMCI & MRNA Exit
10:03am, Monday, 16'th Dec 2024
New names will join the Nasdaq-100. Microstrategy (MSTR) and Palantir (PLTR) will enter the index alongside Axon Enterprise (AXON) later this month.
Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.
11:46am, Friday, 13'th Dec 2024
The Nasdaq is due to announce any changes to the Nasdaq 100 index as part of its annual reconstitution at 8 p.m. ET Friday.
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
08:00am, Thursday, 12'th Dec 2024
SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes
These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over
07:03am, Thursday, 12'th Dec 2024
2024 has been a generally outstanding year for the stock market, with the S&P 500 (^GSPC 0.82%) up by nearly 30% year to date as of Dec. 11. However, not all stocks have performed nearly this well –
Analysts Predict These Will Be Next Year's Top 10 Stocks
08:00am, Wednesday, 11'th Dec 2024
Missed out on this year's top S&P 500 stocks? Analysts are already offering up their ideas on which stocks will rule in 2025.
Growing Incidence of Chronic and Infectious Diseases, Advancements in Synthetic Biology & Bioinformatics, Rising Demand for Personalized Medicine Growing Incidence of Chronic and Infectious Diseases,
